The COVID-19 pandemic has brought medical supply chains into the spotlight. There has been a national shortage of testing kits, and at least one drug is already unavailable because of the outbreak, though it hasn’t been publicly named.
Could chloroquine treat coronavirus? 5 questions answered about a promising, problematic and unproven use for an antimalarial drug
An Arizona man died, and his wife was hospitalized, after taking a form of chloroquine, which President Trump has touted as an effective treatment for COVID-19.
Why defeating coronavirus in one country isn’t enough – there needs to be a coordinated global strategy
Policymakers in countries where there are severe outbreaks of COVID-19 are doing what they can to slow the spread and “flatten the curve.” But so far, there hasn’t been much global coordination, raising the risk of a second wave of contamination even after individual countries halt the virus’ advance.
Students could be undercounted in the census as coronavirus closes colleges – here’s why that matters
At college dormitories and student apartments across the U.S., census forms will be piling up – but many run the risk of not being filled in.The spread of the coronavirus in the U.S. has coincided with the start of data collection for the 2020 census.
‘My first question every time I see a new patient now is: Could this be COVID-19?’ A Seattle doctor on the frontlines
Everything feels different in the hospital now. I am an emergency and critical care physician who cares for patients in the emergency department and intensive care units at Seattle’s Harborview Medical Center, a public hospital with 413 beds owned by King County and staffed by doctors from the University of Washington School of Medicine.